default author photo

Chrystal M. Paulos

Emory University

SCHOLARLY PAPERS

1

DOWNLOADS

35

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

A Phase Ib/Ii Trial of Xl888 (Hsp90 Inhibitor) and Pembrolizumab in Metastatic Pancreatic Cancer with Translational Immune Profiling

Number of pages: 51 Posted: 06 Aug 2025
Emory University, Henry Ford Health System - Henry Ford Hospital, Emory University, affiliation not provided to SSRN, Emory University - Department of Hematology and Medical Oncology, Emory University, Emory University, Emory University, affiliation not provided to SSRN, Emory University, Emory University, Emory University - Emory University Hospital, Emory University, Emory University, University of Alabama at Birmingham and Emory University
Downloads 35 (1,263,436)

Abstract:

Loading...

PDAC, checkpoint inhibition, HSP90 inhibition, Liver metastasis, Immunotherapy resistance